These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8397246)

  • 1. Antihypertensive activity of verapamil: impact of dietary sodium. The VERSAL Study Group.
    Redón-Más J; Abellán-Alemán J; Aranda-Lara P; de la Figuera-von Wichmann M; Luque-Otero M; Rodicio-Díaz JL; Ruilope-Urioste LM; Velasco-Quintana J
    J Hypertens; 1993 Jun; 11(6):665-71. PubMed ID: 8397246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do changes in dietary salt influence blood pressure of hypertensive patients pharmacologically controlled with verapamil? The Salt-Switching-Study (SSS).
    Redón J; Lozano JV; de la Figuera M; Rodriguez JC; Garrido J; Alés-Martínez JE; Alvarez-Cantalapiedra I; Velasco-Quintana J
    J Hum Hypertens; 1995 Feb; 9(2):143-7. PubMed ID: 7752177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.
    Weir MR; Chrysant SG; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Lewin AJ; Mennella RF; Kirkegaard LW; Hamilton JH; Weinberger MH; Weder AB
    Hypertension; 1998 May; 31(5):1088-96. PubMed ID: 9576119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antihypertensive effect of verapamil at extremes of dietary sodium intake.
    Nicholson JP; Resnick LM; Laragh JH
    Ann Intern Med; 1987 Sep; 107(3):329-34. PubMed ID: 3619222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency.
    Ruilope LM; Casal MC; Guerrero L; Alcázar JM; Férnandez ML; Lahera V; Rodicio JL
    Drugs; 1992; 44 Suppl 1():94-8. PubMed ID: 1283591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt sensitivity and the blood pressure response to verapamil.
    Weinberger MH; Wagner UL; Fineberg NS
    Am J Hypertens; 1994 Jun; 7(6):515-9. PubMed ID: 7917149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and renal effects of orally administered verapamil.
    Leonetti G; Sala C; Bianchini C; Terzoli L; Zanchetti A
    Eur J Clin Pharmacol; 1980 Nov; 18(5):375-82. PubMed ID: 7002568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort.
    Fuchs FD; Gus M; Moreira WD; Moreira LB; Moraes RS; Rosito GA; Sorucco A; Atanázio P; Machado R
    J Hypertens; 1997 Jul; 15(7):783-92. PubMed ID: 9222947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schriger A
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
    García de Vinuesa S; Luño J; Gómez-Campderá F; Ridao N; Sánchez M; Dall'Anese C; Valderrábano F
    Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium supplementation in patients with essential hypertension: assessment by office, home and ambulatory blood pressure.
    Kawano Y; Yoshimi H; Matsuoka H; Takishita S; Omae T
    J Hypertens; 1998 Nov; 16(11):1693-9. PubMed ID: 9856371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
    Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of moderate sodium restriction on clinic and twenty-four-hour ambulatory blood pressure in elderly hypertensive subjects.
    Fotherby MD; Potter JF
    J Hypertens; 1993 Jun; 11(6):657-63. PubMed ID: 8397245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators.
    Rosei EA; Dal Palù C; Leonetti G; Magnani B; Pessina A; Zanchetti A
    J Hypertens; 1997 Nov; 15(11):1337-44. PubMed ID: 9383184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
    Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
    J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive efficacy of a once a day verapamil SR/trandolapril combination.
    Oren S; Viskoper JR; Zilles P
    Int J Cardiol; 1996 Jul; 55(1):97-102. PubMed ID: 8839816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of salt restriction and the response to antihypertensive drugs. Satellite symposium on calcium antagonists.
    Luft FC; Weinberger MH
    Hypertension; 1988 Feb; 11(2 Pt 2):I229-32. PubMed ID: 2894358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.